Methyl 4-(1H-imidazol-1-yl)benzoate

Catalog No. :
ACULVG472
CAS No. :
101184-08-1
Molecular Formula :
C11H10N2O2
Molecular Weight :
202.21

IUPAC Name:methyl 4-(1H-imidazol-1-yl)benzoate

Methyl 4-(1H-imidazol-1-yl)benzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$53.00Login to see priceIn stockInquiry
10g98%$89.00Login to see priceIn stockInquiry
25g98%$172.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 4-(1H-imidazol-1-yl)benzoate
IUPAC Namemethyl 4-(1H-imidazol-1-yl)benzoate
MDL No.MFCD00127080
Molecular FormulaC11H10N2O2
Molecular Weight202.21
SMILESO=C(OC)C1=CC=C(N2C=CN=C2)C=C1
InChI KeyKUBBZTZQWIGHFH-UHFFFAOYSA-N
SynonymAKOS005069465 | Methyl 4-(1H-imidazol-1-yl)benzoate, 99% | AMY29165 | J-522220 | KUBBZTZQWIGHFH-UHFFFAOYSA-N | HMS2593K21 | MLS000694657 | methyl 4-imidazol-1-ylbenzoate | Methyl 4-(1-Imidazolyl)benzoate | SMR000332960 | DTXSID00377582 | HMS1364K01 | MFCD
CAS No.101184-08-1
PubChem CID2766374

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACULVG472 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNRGL042 route compound structure diagram
    ACNRGL042403-33-8 In Stock
  2. Plus
  3. ACDLYM406 route compound structure diagram
    ACDLYM4065587-42-8 In Stock
  4. Then
  5. ACULVG472 route product structure diagram
    ACULVG472101184-08-1 In Stock
Inquiry

2. ACULVG472 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBOVU410 route compound structure diagram
    ACBOVU41099768-12-4 In Stock
  2. Plus
  3. ACDLYM406 route compound structure diagram
    ACDLYM4065587-42-8 In Stock
  4. Then
  5. ACULVG472 route product structure diagram
    ACULVG472101184-08-1 In Stock
Inquiry

Comments (0)